HEADER TRANSFERASE 22-MAR-13 4BFZ TITLE CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PANK IN COMPLEX WITH A TITLE 2 BIARYL INHIBITORY COMPOUND (2B) AND PHOSPHATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: PANTOTHENATE KINASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PANTOTHENIC ACID KINASE; COMPND 5 EC: 2.7.1.33; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS; SOURCE 3 ORGANISM_TAXID: 83332; SOURCE 4 STRAIN: H37RV; SOURCE 5 ATCC: 25618; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS TRANSFERASE, COA PATHWAY, PANK, INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR C.BJORKELID,T.BERGFORS,T.A.JONES REVDAT 6 20-DEC-23 4BFZ 1 REMARK REVDAT 5 15-MAY-19 4BFZ 1 REMARK REVDAT 4 06-MAR-19 4BFZ 1 REMARK REVDAT 3 10-JUL-13 4BFZ 1 JRNL REVDAT 2 22-MAY-13 4BFZ 1 JRNL REVDAT 1 15-MAY-13 4BFZ 0 JRNL AUTH C.BJORKELID,T.BERGFORS,A.K.V.RAICHURKAR,K.MUKHERJEE, JRNL AUTH 2 M.KRISHNAN,B.BANDODKAR,T.A.JONES JRNL TITL STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF COMPOUNDS JRNL TITL 2 INHIBITING MYCOBACTERIUM TUBERCULOSIS PANK JRNL REF J.BIOL.CHEM. V. 288 18260 2013 JRNL REFN ISSN 0021-9258 JRNL PMID 23661699 JRNL DOI 10.1074/JBC.M113.476473 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.7.0029 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 56.89 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 46841 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.207 REMARK 3 R VALUE (WORKING SET) : 0.205 REMARK 3 FREE R VALUE : 0.248 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2501 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.16 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3395 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.2510 REMARK 3 BIN FREE R VALUE SET COUNT : 183 REMARK 3 BIN FREE R VALUE : 0.2720 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4942 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 76 REMARK 3 SOLVENT ATOMS : 289 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.99000 REMARK 3 B22 (A**2) : -0.33000 REMARK 3 B33 (A**2) : 3.33000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.199 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.178 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.130 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.924 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.945 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.919 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5142 ; 0.009 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6996 ; 1.501 ; 1.974 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 610 ; 5.809 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 252 ;33.682 ;22.063 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 830 ;18.403 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 62 ;19.212 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 774 ; 0.092 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3966 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 4BFZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 22-MAR-13. REMARK 100 THE DEPOSITION ID IS D_1290056258. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 07-SEP-08 REMARK 200 TEMPERATURE (KELVIN) : 110 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-4 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97950 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 49393 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 58.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 6.900 REMARK 200 R MERGE (I) : 0.11000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.21 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 7.10 REMARK 200 R MERGE FOR SHELL (I) : 0.49000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 4BFS REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.74 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.91 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SITTING-DROP VAPOR-DIFFUSION METHOD AT REMARK 280 293 K. 1.8 M SODIUM/POTASSIUM PHOSPHATE, PH 8.2, VAPOR DIFFUSION, REMARK 280 SITTING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 44.23000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 74.14000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 44.23000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 74.14000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4980 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27390 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -45.4 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A2141 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS A -5 REMARK 465 HIS A -4 REMARK 465 HIS A -3 REMARK 465 HIS A -2 REMARK 465 HIS A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 ARG A 3 REMARK 465 LEU A 4 REMARK 465 SER A 5 REMARK 465 GLU A 6 REMARK 465 HIS B -5 REMARK 465 HIS B -4 REMARK 465 HIS B -3 REMARK 465 HIS B -2 REMARK 465 HIS B -1 REMARK 465 HIS B 0 REMARK 465 MET B 1 REMARK 465 SER B 2 REMARK 465 ARG B 3 REMARK 465 LEU B 4 REMARK 465 SER B 5 REMARK 465 GLU B 6 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 2029 O HOH A 2030 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 26 C - N - CA ANGL. DEV. = 18.4 DEGREES REMARK 500 PRO A 26 C - N - CD ANGL. DEV. = -19.0 DEGREES REMARK 500 LEU A 222 CA - CB - CG ANGL. DEV. = 16.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 26 72.91 28.89 REMARK 500 LEU A 40 43.24 -108.50 REMARK 500 GLU A 42 -36.20 169.37 REMARK 500 GLU A 80 75.48 26.37 REMARK 500 HIS A 120 66.29 -152.46 REMARK 500 THR A 211 -150.29 -129.04 REMARK 500 THR A 245 -93.61 -108.71 REMARK 500 ILE A 276 -62.80 -127.69 REMARK 500 PRO A 290 0.13 -69.74 REMARK 500 HIS A 302 3.29 82.98 REMARK 500 THR B 25 124.56 61.99 REMARK 500 ALA B 28 171.86 -57.78 REMARK 500 LEU B 40 7.26 -153.29 REMARK 500 GLU B 42 -43.82 81.84 REMARK 500 GLU B 80 67.02 28.43 REMARK 500 HIS B 120 66.87 -151.73 REMARK 500 THR B 211 -138.36 -131.39 REMARK 500 THR B 245 -98.30 -105.18 REMARK 500 ILE B 276 -66.29 -126.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZVZ A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PO4 B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZVZ B 501 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4BFS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PANK IN COMPLEX REMARK 900 WITH A TRIAZOLE INHIBITORY COMPOUND (1A) REMARK 900 RELATED ID: 4BFT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PANK IN COMPLEX REMARK 900 WITH A TRIAZOLE INHIBITORY COMPOUND (1B) AND PHOSPHATE REMARK 900 RELATED ID: 4BFU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PANK IN COMPLEX REMARK 900 WITH A TRIAZOLE INHIBITORY COMPOUND (1C) AND PHOSPHATE REMARK 900 RELATED ID: 4BFV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PANK IN COMPLEX REMARK 900 WITH A TRIAZOLE INHIBITORY COMPOUND (1D) AND PHOSPHATE REMARK 900 RELATED ID: 4BFW RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PANK IN COMPLEX REMARK 900 WITH A TRIAZOLE INHIBITORY COMPOUND (1E) AND PHOSPHATE REMARK 900 RELATED ID: 4BFX RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PANK IN COMPLEX REMARK 900 WITH A TRIAZOLE INHIBITORY COMPOUND (1F) AND PHOSPHATE REMARK 900 RELATED ID: 4BFY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PANK IN COMPLEX REMARK 900 WITH A BIARYL INHIBITORY COMPOUND (2A) AND PHOSPHATE DBREF 4BFZ A 1 312 UNP P63810 COAA_MYCTU 1 312 DBREF 4BFZ B 1 312 UNP P63810 COAA_MYCTU 1 312 SEQADV 4BFZ HIS A -5 UNP P63810 EXPRESSION TAG SEQADV 4BFZ HIS A -4 UNP P63810 EXPRESSION TAG SEQADV 4BFZ HIS A -3 UNP P63810 EXPRESSION TAG SEQADV 4BFZ HIS A -2 UNP P63810 EXPRESSION TAG SEQADV 4BFZ HIS A -1 UNP P63810 EXPRESSION TAG SEQADV 4BFZ HIS A 0 UNP P63810 EXPRESSION TAG SEQADV 4BFZ HIS B -5 UNP P63810 EXPRESSION TAG SEQADV 4BFZ HIS B -4 UNP P63810 EXPRESSION TAG SEQADV 4BFZ HIS B -3 UNP P63810 EXPRESSION TAG SEQADV 4BFZ HIS B -2 UNP P63810 EXPRESSION TAG SEQADV 4BFZ HIS B -1 UNP P63810 EXPRESSION TAG SEQADV 4BFZ HIS B 0 UNP P63810 EXPRESSION TAG SEQRES 1 A 318 HIS HIS HIS HIS HIS HIS MET SER ARG LEU SER GLU PRO SEQRES 2 A 318 SER PRO TYR VAL GLU PHE ASP ARG ARG GLN TRP ARG ALA SEQRES 3 A 318 LEU ARG MET SER THR PRO LEU ALA LEU THR GLU GLU GLU SEQRES 4 A 318 LEU VAL GLY LEU ARG GLY LEU GLY GLU GLN ILE ASP LEU SEQRES 5 A 318 LEU GLU VAL GLU GLU VAL TYR LEU PRO LEU ALA ARG LEU SEQRES 6 A 318 ILE HIS LEU GLN VAL ALA ALA ARG GLN ARG LEU PHE ALA SEQRES 7 A 318 ALA THR ALA GLU PHE LEU GLY GLU PRO GLN GLN ASN PRO SEQRES 8 A 318 ASP ARG PRO VAL PRO PHE ILE ILE GLY VAL ALA GLY SER SEQRES 9 A 318 VAL ALA VAL GLY LYS SER THR THR ALA ARG VAL LEU GLN SEQRES 10 A 318 ALA LEU LEU ALA ARG TRP ASP HIS HIS PRO ARG VAL ASP SEQRES 11 A 318 LEU VAL THR THR ASP GLY PHE LEU TYR PRO ASN ALA GLU SEQRES 12 A 318 LEU GLN ARG ARG ASN LEU MET HIS ARG LYS GLY PHE PRO SEQRES 13 A 318 GLU SER TYR ASN ARG ARG ALA LEU MET ARG PHE VAL THR SEQRES 14 A 318 SER VAL LYS SER GLY SER ASP TYR ALA CYS ALA PRO VAL SEQRES 15 A 318 TYR SER HIS LEU HIS TYR ASP ILE ILE PRO GLY ALA GLU SEQRES 16 A 318 GLN VAL VAL ARG HIS PRO ASP ILE LEU ILE LEU GLU GLY SEQRES 17 A 318 LEU ASN VAL LEU GLN THR GLY PRO THR LEU MET VAL SER SEQRES 18 A 318 ASP LEU PHE ASP PHE SER LEU TYR VAL ASP ALA ARG ILE SEQRES 19 A 318 GLU ASP ILE GLU GLN TRP TYR VAL SER ARG PHE LEU ALA SEQRES 20 A 318 MET ARG THR THR ALA PHE ALA ASP PRO GLU SER HIS PHE SEQRES 21 A 318 HIS HIS TYR ALA ALA PHE SER ASP SER GLN ALA VAL VAL SEQRES 22 A 318 ALA ALA ARG GLU ILE TRP ARG THR ILE ASN ARG PRO ASN SEQRES 23 A 318 LEU VAL GLU ASN ILE LEU PRO THR ARG PRO ARG ALA THR SEQRES 24 A 318 LEU VAL LEU ARG LYS ASP ALA ASP HIS SER ILE ASN ARG SEQRES 25 A 318 LEU ARG LEU ARG LYS LEU SEQRES 1 B 318 HIS HIS HIS HIS HIS HIS MET SER ARG LEU SER GLU PRO SEQRES 2 B 318 SER PRO TYR VAL GLU PHE ASP ARG ARG GLN TRP ARG ALA SEQRES 3 B 318 LEU ARG MET SER THR PRO LEU ALA LEU THR GLU GLU GLU SEQRES 4 B 318 LEU VAL GLY LEU ARG GLY LEU GLY GLU GLN ILE ASP LEU SEQRES 5 B 318 LEU GLU VAL GLU GLU VAL TYR LEU PRO LEU ALA ARG LEU SEQRES 6 B 318 ILE HIS LEU GLN VAL ALA ALA ARG GLN ARG LEU PHE ALA SEQRES 7 B 318 ALA THR ALA GLU PHE LEU GLY GLU PRO GLN GLN ASN PRO SEQRES 8 B 318 ASP ARG PRO VAL PRO PHE ILE ILE GLY VAL ALA GLY SER SEQRES 9 B 318 VAL ALA VAL GLY LYS SER THR THR ALA ARG VAL LEU GLN SEQRES 10 B 318 ALA LEU LEU ALA ARG TRP ASP HIS HIS PRO ARG VAL ASP SEQRES 11 B 318 LEU VAL THR THR ASP GLY PHE LEU TYR PRO ASN ALA GLU SEQRES 12 B 318 LEU GLN ARG ARG ASN LEU MET HIS ARG LYS GLY PHE PRO SEQRES 13 B 318 GLU SER TYR ASN ARG ARG ALA LEU MET ARG PHE VAL THR SEQRES 14 B 318 SER VAL LYS SER GLY SER ASP TYR ALA CYS ALA PRO VAL SEQRES 15 B 318 TYR SER HIS LEU HIS TYR ASP ILE ILE PRO GLY ALA GLU SEQRES 16 B 318 GLN VAL VAL ARG HIS PRO ASP ILE LEU ILE LEU GLU GLY SEQRES 17 B 318 LEU ASN VAL LEU GLN THR GLY PRO THR LEU MET VAL SER SEQRES 18 B 318 ASP LEU PHE ASP PHE SER LEU TYR VAL ASP ALA ARG ILE SEQRES 19 B 318 GLU ASP ILE GLU GLN TRP TYR VAL SER ARG PHE LEU ALA SEQRES 20 B 318 MET ARG THR THR ALA PHE ALA ASP PRO GLU SER HIS PHE SEQRES 21 B 318 HIS HIS TYR ALA ALA PHE SER ASP SER GLN ALA VAL VAL SEQRES 22 B 318 ALA ALA ARG GLU ILE TRP ARG THR ILE ASN ARG PRO ASN SEQRES 23 B 318 LEU VAL GLU ASN ILE LEU PRO THR ARG PRO ARG ALA THR SEQRES 24 B 318 LEU VAL LEU ARG LYS ASP ALA ASP HIS SER ILE ASN ARG SEQRES 25 B 318 LEU ARG LEU ARG LYS LEU HET PO4 A 401 5 HET ZVZ A 501 33 HET PO4 B 401 5 HET ZVZ B 501 33 HETNAM PO4 PHOSPHATE ION HETNAM ZVZ 2-[4-(4-CYANOPHENYL)-3-{[4-(PYRIDIN-2-YL)PIPERAZIN-1- HETNAM 2 ZVZ YL]METHYL}PHENOXY]-N-METHYLACETAMIDE FORMUL 3 PO4 2(O4 P 3-) FORMUL 4 ZVZ 2(C26 H27 N5 O2) FORMUL 7 HOH *289(H2 O) HELIX 1 1 ARG A 15 LEU A 21 1 7 HELIX 2 2 THR A 30 GLY A 39 1 10 HELIX 3 3 ASP A 45 VAL A 52 1 8 HELIX 4 4 VAL A 52 LEU A 78 1 27 HELIX 5 5 GLY A 102 ALA A 115 1 14 HELIX 6 6 ASP A 129 PHE A 131 5 3 HELIX 7 7 PRO A 134 ARG A 141 1 8 HELIX 8 8 LEU A 143 LYS A 147 5 5 HELIX 9 9 PHE A 149 SER A 152 5 4 HELIX 10 10 ASN A 154 SER A 167 1 14 HELIX 11 11 MET A 213 PHE A 218 5 6 HELIX 12 12 ARG A 227 ARG A 243 1 17 HELIX 13 13 THR A 245 ASP A 249 5 5 HELIX 14 14 PHE A 254 ALA A 258 5 5 HELIX 15 15 SER A 261 ILE A 276 1 16 HELIX 16 16 ILE A 276 ASN A 284 1 9 HELIX 17 17 ILE A 285 ALA A 292 5 8 HELIX 18 18 ARG B 15 LEU B 21 1 7 HELIX 19 19 THR B 30 GLY B 39 1 10 HELIX 20 20 ASP B 45 VAL B 52 1 8 HELIX 21 21 VAL B 52 LEU B 78 1 27 HELIX 22 22 GLY B 102 ALA B 115 1 14 HELIX 23 23 ASP B 129 PHE B 131 5 3 HELIX 24 24 PRO B 134 ARG B 141 1 8 HELIX 25 25 LEU B 143 LYS B 147 5 5 HELIX 26 26 PHE B 149 SER B 152 5 4 HELIX 27 27 ASN B 154 SER B 167 1 14 HELIX 28 28 MET B 213 PHE B 218 5 6 HELIX 29 29 ARG B 227 ARG B 243 1 17 HELIX 30 30 PHE B 254 PHE B 260 5 7 HELIX 31 31 SER B 261 ILE B 276 1 16 HELIX 32 32 ILE B 276 ILE B 285 1 10 HELIX 33 33 LEU B 286 ALA B 292 5 7 SHEET 1 AA 7 TYR A 10 ASP A 14 0 SHEET 2 AA 7 ILE A 304 ARG A 310 -1 O LEU A 307 N PHE A 13 SHEET 3 AA 7 LEU A 294 LYS A 298 -1 O VAL A 295 N ARG A 308 SHEET 4 AA 7 PHE A 220 ALA A 226 1 O SER A 221 N LEU A 294 SHEET 5 AA 7 PHE A 91 GLY A 97 1 O GLY A 94 N LEU A 222 SHEET 6 AA 7 ILE A 197 GLU A 201 1 O LEU A 198 N ILE A 93 SHEET 7 AA 7 VAL A 123 THR A 127 1 O ASP A 124 N ILE A 199 SHEET 1 AB 2 ALA A 172 SER A 178 0 SHEET 2 AB 2 ASP A 183 VAL A 192 -1 O ASP A 183 N SER A 178 SHEET 1 BA 7 TYR B 10 ASP B 14 0 SHEET 2 BA 7 ILE B 304 ARG B 310 -1 O LEU B 307 N PHE B 13 SHEET 3 BA 7 LEU B 294 LYS B 298 -1 O VAL B 295 N ARG B 308 SHEET 4 BA 7 PHE B 220 ALA B 226 1 O SER B 221 N LEU B 294 SHEET 5 BA 7 PHE B 91 GLY B 97 1 O GLY B 94 N LEU B 222 SHEET 6 BA 7 ILE B 197 GLU B 201 1 O LEU B 198 N ILE B 93 SHEET 7 BA 7 VAL B 123 THR B 127 1 O ASP B 124 N ILE B 199 SHEET 1 BB 2 ALA B 172 SER B 178 0 SHEET 2 BB 2 ASP B 183 VAL B 192 -1 O ASP B 183 N SER B 178 CISPEP 1 THR A 25 PRO A 26 0 25.67 SITE 1 AC1 9 SER A 98 ALA A 100 VAL A 101 GLY A 102 SITE 2 AC1 9 LYS A 103 SER A 104 ARG A 238 HOH A2048 SITE 3 AC1 9 HOH A2049 SITE 1 AC2 18 ASP A 129 MET A 144 HIS A 145 LYS A 147 SITE 2 AC2 18 GLY A 148 TYR A 182 TYR A 235 PHE A 239 SITE 3 AC2 18 MET A 242 PHE A 247 PHE A 254 ILE A 276 SITE 4 AC2 18 ASN A 277 HOH A2090 HOH A2118 HOH A2119 SITE 5 AC2 18 GLU B 271 ARG B 274 SITE 1 AC3 9 SER B 98 ALA B 100 VAL B 101 GLY B 102 SITE 2 AC3 9 LYS B 103 SER B 104 ARG B 238 HOH B2008 SITE 3 AC3 9 HOH B2036 SITE 1 AC4 16 GLU A 271 ARG A 274 ASP B 129 MET B 144 SITE 2 AC4 16 HIS B 145 LYS B 147 TYR B 182 TYR B 235 SITE 3 AC4 16 PHE B 239 MET B 242 PHE B 247 PHE B 254 SITE 4 AC4 16 ILE B 276 ASN B 277 HOH B2073 HOH B2092 CRYST1 88.460 148.280 63.260 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011305 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006744 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015808 0.00000